The US Food and Drug Administration on Monday approved Roche's new breast cancer drug Wilserdly (giredestrant), a medicine the Swiss company has said could become its top-selling product ever. STAT
STATFDA approves new breast cancer drug, providing new option for some patients, boost for RocheThe FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever.
How much should a company's sales forecast matter when regulators weigh a new cancer drug, if at all?